JUM Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Wood, A. K. W.
Right arrow Articles by Sehgal, C. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, A. K. W.
Right arrow Articles by Sehgal, C. M.
© 2009 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 28:795-800 • 0278-4297


Technical Advance

Acute Increases in Murine Tumor Echogenicity After Antivascular Ultrasound Therapy

A Pilot Preclinical Study

Andrew K. W. Wood, DVSc, PhD, Ralph M. Bunte, DVM, Susan M. Schultz, RDMS and Chandra M. Sehgal, PhD

Department of Clinical Studies, School of Veterinary Medicine (A.K.W.W.), University Laboratory Animal Resources (R.M.B.), and Department of Radiology (S.M.S., C.M.S.), University of Pennsylvania, Philadelphia, Pennsylvania USA.

Address correspondence to Chandra M. Sehgal, PhD, Department of Radiology, University of Pennsylvania Medical Center, 3400 Spruce St, Philadelphia, PA 19104 USA. E-mail: sehgalc{at}uphs.upenn.edu

Objective. This study was designed to determine whether the echogenicity of neoplastic tissues changed as a result of low-intensity insonation and whether such alterations were related to an anti-vascular effect. Methods. In 21 mice, implanted melanomas were insonated at either 1, 2, or 3 MHz using low-intensity ultrasound (spatial-average temporal-average intensity, 2.1 W/cm2). B-mode (mean gray scale) and contrast-enhanced power Doppler (percentage area of flow) measurements were made on each tumor before and after therapy. Results. There was an increase in the echogenicity of the tumors with the increase in the frequency of the therapy beam and an accompanying decrease in tumor vascularity. Conclusions. Although the mechanisms responsible for the echogenicity change are not fully understood, it appears that an increase in the tumor mean gray scale was, at least in part, related to tissue inhomogeneities formed after disruption of the tumor neovasculature.

Key Words: antivascular ultrasound therapy • B-mode gray scale • vascular disrupting agent

Abbreviations: PAF, percentage area of flow







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Institute of Ultrasound in Medicine.